Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials.

Saifi, Omran; Bachir, Bachir; Panoff, Joseph; Poortmans, Philip; Zeidan, Youssef H

Saifi, Omran; Bachir, Bachir; Panoff, Joseph; Poortmans, Philip; Zeidan, Youssef H.

Afiliación

Saifi O; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.
Bachir B; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Panoff J; Department of Radiation Oncology, Baptist Health of South Florida, Miami, FL, USA.
Poortmans P; Iridium Netwerk, Wilrijk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk, Antwerp, Belgium.
Zeidan YH; Faculty of Medicine, American University of Beirut, Beirut, Lebanon; Lynn Cancer Institute, Baptist Health of South Florida, Boca Raton, FL, USA. Electronic address: Youssef.Zeidan@baptisthealth.net.

Radiother Oncol ; 184: 109668, 2023 07.

Article en En | MEDLINE | ID: mdl-37030399

Asunto(s)

Neoplasias de la Mama; Humanos; Femenino; Neoplasias de la Mama/radioterapia; Neoplasias de la Mama/tratamiento farmacológico; Mastectomía; Análisis Multivariante; Terapia Neoadyuvante/métodos; Radioterapia Adyuvante/métodos; Recurrencia Local de Neoplasia/patología; Estadificación de Neoplasias; Estudios Retrospectivos

Palabras clave

Anti-HER2 targeted therapy; Complete pathological response; HER-2 positive breast cancer; Neoadjuvant; Primary systemic therapy; Radiation therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google